Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
Cure Mucolipidosis
990EZ • Fiscal year 2024 • EIN 86-3929222
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
No value available
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
97th percentile
Higher net margin than 97% of similar nonprofits.
Top Officer Pay
79th percentile
Higher top officer pay than 79% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
94th percentile
Faster asset growth than 94% of similar nonprofits.
Revenue Growth
74th percentile
Faster revenue growth than 74% of similar nonprofits.
Balance Sheet
Assets
Up$97,169
Up $57,898 (+147%) from 2023
Net Assets
Up$97,169
Up $57,898 (+147%) from 2023
Liabilities
-
No earlier filing loaded for comparison.
Revenue And Expenses
Revenue
Up$67,567
Up $14,768 (+28%) from 2023
Expenses
Down$9,669
Down $33,683 (-78%) from 2023
Net Income
Up$57,898
Up $48,451 (+513%) from 2023
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2024 to Dec 31, 2024
- Signed
- Feb 26, 2025
- Return Version
- 2024v5.0
- Gross Receipts
- $67,567
Mission and Program Overview
Mission
Cure mucolipidosis is a global organization that is committed to the identification and treatment of mucolipidosis through education, advocacy and research. Cure mucolipidosis will form partnerships with science, medicine and industry and will work towards finding a cure for people affected by mucolipidosis globally.
Cure mucolipidosis is a global organization that is committed to the identification and treatment of mucolipidosis through education, advocacy and research.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| WE CO-FUNDED A RESEARCH PROJECT TO LOOK AT DRUG UPTAKE IN MUCOLIPIDOSIS TO FIND OUT WHY PATIENTS SEEM TO HAVE LESS RESPONSE TO PAIN MEDICATION. WORKED TO SECURE AN AGREEMENT WITH UMASS TO START THE JOURNEY OF GENE THERAPY FOR MUCOLIPIDOSIS. | - | - |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| JACQUELINE JAMES | President | PT | $0 | - | - |
| JENNY NOBLE | Secretary | PT | $0 | - | - |
| KEVIN GATES | Treasurer | - | $0 | - | - |
| SUSAN KESTER | Board Member | - | $0 | - | - |
| NADIA JACK | Board Member | - | $0 | - | - |
| SUE WENG | Board Member | - | $0 | - | - |
| CHARLOETTE GILBERT | Board Member | - | $0 | - | - |
| TRULS ROLL | Board Member | - | $0 | - | - |
| JOHN DELANEY | Board Member | PT | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Cure Mucolipidosis
- EIN
- 86-3929222
- Phone
- 3146407844
- Address
- 402 PARK AVE, BELLEVILLE, IL 62220-3827
Signing Officer
- Name
- Jacqueline James
- Title
- President
- Phone
- 3146407844
- Signed
- 2025-02-26
Preparer
- Firm
- Brytebridge Consulting LLC
- Address
- 7021 UNIVERSITY BLVD, WINTER PARK, FL 32792-6719
- Preparer
- Maria Tapia
- Phone
- 8778579002
Supplemental Narrative
Additional Explanations
Form 990-ez, Part I, Line 16
“Expenses advertising and promotion 174 office 1,601 licenses 1,657 bank fees 351 subscriptions 254 miscellaneous 76 merchant fees 5,135 business expense 227 total 9,475”
Form 990-ez, Part III
“Cure mucolipidosis is a global organization that is committed to the identification and treatment of mucolipidosis through education, advocacy and research.”
Form 990-ez, Part III, Line 28
“We co-funded a research project to look at drug uptake in mucolipidosis to find out why patients seem to have less response to pain medication. Worked to secure an agreement with umass to start the journey of gene therapy for mucolipidosis.”
Raw XML Appendix140 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | JACQUELINE JAMES |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 3146407844 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 402 PARK AVE |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | BELLEVILLE |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | IL |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 62220 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 39271 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 97169 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 67567 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 57898 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 39271 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 97169 |
| IRS990EZ/GrossReceiptsAmt | 0 | 67567 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingCashInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 39271 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 97169 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 39271 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 97169 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 8.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 10.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 6 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 7 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 8 | 5.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 6 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 7 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 8 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | JACQUELINE JAMES |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | JENNY NOBLE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | KEVIN GATES |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | SUSAN KESTER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | NADIA JACK |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | SUE WENG |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 6 | CHARLOETTE GILBERT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 7 | TRULS ROLL |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 8 | JOHN DELANEY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | PRESIDENT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | SECRETARY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | TREASURER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | BOARD MEMBER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | BOARD MEMBER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | BOARD MEMBER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 6 | BOARD MEMBER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 7 | BOARD MEMBER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 8 | BOARD MEMBER |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 9475 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | CURE MUCOLIPIDOSIS IS A GLOBAL ORGANIZATION THAT IS COMMITTED TO THE IDENTIFICATION AND TREATMENT OF MUCOLIPIDOSIS THROUGH EDUCATION, ADVOCACY AND RESEARCH. |
| IRS990EZ/PrintingPublicationsPostageAmt | 0 | 194 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | WE CO-FUNDED A RESEARCH PROJECT TO LOOK AT DRUG UPTAKE IN MUCOLIPIDOSIS TO FIND OUT WHY PATIENTS SEEM TO HAVE LESS RESPONSE TO PAIN MEDICATION. WORKED TO SECURE AN AGREEMENT WITH UMASS TO START THE JOURNEY OF GENE THERAPY FOR MUCOLIPIDOSIS. |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/ScheduleBNotRequiredInd | 0 | X |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 0 | IL |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 9669 |
| IRS990EZ/TotalRevenueAmt | 0 | 67567 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.CUREMUCOLIPIDOSIS.ORG |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt | 0 | 67567 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt | 0 | 52799 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 131060 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 4327 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt | 0 | 255753 |
| IRS990ScheduleA/PublicOrganization170Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY170Pct | 0 | 0.98100 |
| IRS990ScheduleA/PublicSupportTotal170Amt | 0 | 250888 |
| IRS990ScheduleA/SubstantialContributorsTotAmt | 0 | 4865 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind | 0 | X |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt | 0 | 67567 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt | 0 | 52799 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 131060 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 4327 |
| IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt | 0 | 255753 |
| IRS990ScheduleA/TotalSupportAmt | 0 | 255753 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES ADVERTISING AND PROMOTION 174 OFFICE 1,601 LICENSES 1,657 BANK FEES 351 SUBSCRIPTIONS 254 MISCELLANEOUS 76 MERCHANT FEES 5,135 BUSINESS EXPENSE 227 TOTAL 9,475 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | CURE MUCOLIPIDOSIS IS A GLOBAL ORGANIZATION THAT IS COMMITTED TO THE IDENTIFICATION AND TREATMENT OF MUCOLIPIDOSIS THROUGH EDUCATION, ADVOCACY AND RESEARCH. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | WE CO-FUNDED A RESEARCH PROJECT TO LOOK AT DRUG UPTAKE IN MUCOLIPIDOSIS TO FIND OUT WHY PATIENTS SEEM TO HAVE LESS RESPONSE TO PAIN MEDICATION. WORKED TO SECURE AN AGREEMENT WITH UMASS TO START THE JOURNEY OF GENE THERAPY FOR MUCOLIPIDOSIS. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART III, LINE 28 |
| ReturnHeader/BuildTS | 0 | 2025-03-06 01:10:19Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | JACQUELINE JAMES |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | PRESIDENT |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 3146407844 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2025-02-26 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | CURE MUCOLIPIDOSIS |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | CURE |
| ReturnHeader/Filer/EIN | 0 | 863929222 |
| ReturnHeader/Filer/PhoneNum | 0 | 3146407844 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 402 PARK AVE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | BELLEVILLE |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | IL |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 622203827 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | false |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 843085028 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | BRYTEBRIDGE CONSULTING LLC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 7021 UNIVERSITY BLVD |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | WINTER PARK |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | FL |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 327926719 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 8778579002 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2025-03-12 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | MARIA TAPIA |
| ReturnHeader/ReturnTs | 0 | 2025-03-12T16:17:13-04:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2024-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2024-12-31 |
| ReturnHeader/TaxYr | 0 | 2024 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $97,169
- Liabilities
- -
- Net assets
- $97,169
- Revenue
- $67,567
- Expenses
- $9,669
- Net income
- $57,898
| Balance Sheet | Operations | |||||
|---|---|---|---|---|---|---|
| Year | Assets | Liabilities | Net Assets | Revenue | Expenses | Net Income |
| 2024Detailed filing. Detailed filing data is available for this year. | $0.97 | $0.97 | $0.68 | $0.10 | $0.58 | |
| 2023Detailed filing. Detailed filing data is available for this year. | $0.39 | $0.00 | $0.39 | $0.53 | $0.43 | $0.09 |
| 2022Detailed filing. Detailed filing data is available for this year. | $0.30 | $0.00 | $0.30 | $1.31 | $1.03 | $0.29 |